Indication
Legionella pneumophila pneumonia
*Legionella pneumophila* pneumonia, commonly referred to as Legionnaires' disease, is an acute, potentially severe lower respiratory tract infection caused by the intracellular Gram-negative bacterium *Legionella pneumophila*. Read more about Legionella pneumophila pneumonia
75 drugs 64 manufacturers
Drugs that treat it
Common Legionella pneumophila pneumonia therapies.
LEVOFLOXACIN
LEVOFLOXACIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Legionella pneumophila* pneumonia, commonly referred to as Legionnaires' disease, is an acute, potentially severe lower respiratory tract infection caused by the intracellular Gram-negative bacterium *Legionella pneumophila*.
It primarily affects adults with risk factors such as advanced age, tobacco use, chronic obstructive pulmonary disease, or immunocompromising conditions, and is typically acquired via the inhalation or aspiration of contaminated water aerosols.
Pathophysiologically, the organism proliferates within alveolar macrophages, inciting alveolar inflammation, consolidation, and impaired gas exchange.
Clinically, it manifests as high fever, dyspnea, and a cough that frequently progresses alongside prominent extrapulmonary manifestations, notably gastrointestinal symptoms, neurologic abnormalities, and hyponatremia.
- nih.gov
*Legionella pneumophila* pneumonia, commonly referred to as Legionnaires' disease, is an acute, potentially severe lower respiratory tract infection caused by the intracellular Gram-negative bacterium *Legionella pneumophila*
- merckmanuals.com
*Legionella pneumophila* pneumonia, commonly referred to as Legionnaires' disease, is an acute, potentially severe lower respiratory tract infection caused by the intracellular Gram-negative bacterium *Legionella pneumophila* It primarily affects adults with risk factors such as advanced age, tobacco use, chronic obstructive pulmonary disease, or immunocompromising conditions, and is typically acquired via the inhalation or aspiration of contaminated water aerosols Clinically, it manifests as hi...
- cdc.gov
It primarily affects adults with risk factors such as advanced age, tobacco use, chronic obstructive pulmonary disease, or immunocompromising conditions, and is typically acquired via the inhalation or aspiration of contaminated water aerosols
- nih.gov
Pathophysiologically, the organism proliferates within alveolar macrophages, inciting alveolar inflammation, consolidation, and impaired gas exchange
- youtube.com
Pathophysiologically, the organism proliferates within alveolar macrophages, inciting alveolar inflammation, consolidation, and impaired gas exchange Clinically, it manifests as high fever, dyspnea, and a cough that frequently progresses alongside prominent extrapulmonary manifestations, notably gastrointestinal symptoms, neurologic abnormalities, and hyponatremia
- nih.gov
Clinically, it manifests as high fever, dyspnea, and a cough that frequently progresses alongside prominent extrapulmonary manifestations, notably gastrointestinal symptoms, neurologic abnormalities, and hyponatremia
Personalize your experience
Follow Legionella pneumophila pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.